Immune defense at the ocular surface

被引:93
作者
Akpek, EK [1 ]
Gottsch, JD [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA
关键词
cornea; defensins; calgranulins; neutrophils; herpes; oncocerchiasis;
D O I
10.1038/sj.eye.6700617
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The ocular surface is constantly exposed to a wide array of microorganisms. The ability of the outer ocular system to recognize pathogens as foreign and eliminate them is critical to retain corneal transparency, hence preservation of sight. Therefore, a combination of mechanical, anatomical, and immunological defense mechanisms has evolved to protect the outer eye. These host defense mechanisms are classified as either a native, nonspecific defense or a specifically acquired immunological defense requiring previous exposure to an antigen and the development of specific immunity. Sight-threatening immunopathology with autologous cell damage also can take place after these reactions. This article discusses the innate and acquired corneal elements of the immune defense at the ocular surface. The relative roles of the various factors contributing to prevention of eye infection remain to be fully defined.
引用
收藏
页码:949 / 956
页数:8
相关论文
共 67 条
[1]  
Akpek EK, 2002, INVEST OPHTH VIS SCI, V43, P2677
[2]  
Alberts B., 2002, ADAPTIVE IMMUNE SYST
[3]  
Allman J., 2000, Evolving Brains
[4]   RESISTANCE TO HERPES STROMAL KERATITIS CONFERRED BY AN IGG2A-DERIVED PEPTIDE [J].
AVERY, AC ;
ZHAO, ZS ;
RODRIGUEZ, A ;
BIKOFF, EK ;
SOHEILIAN, M ;
FOSTER, CS ;
CANTOR, H .
NATURE, 1995, 376 (6539) :431-434
[5]   The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis [J].
Bouley, DM ;
Kanangat, S ;
Rouse, BT .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (01) :23-30
[6]  
Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264
[7]   The neutrophil: Function and regulation in innate and humoral immunity [J].
Burg, ND ;
Pillinger, MH .
CLINICAL IMMUNOLOGY, 2001, 99 (01) :7-17
[8]  
Chan C C, 1993, Ocul Immunol Inflamm, V1, P71, DOI 10.3109/09273949309086541
[9]  
CHAN CC, 1989, CLIN EXP IMMUNOL, V77, P367
[10]  
CHANDLER JW, 1985, INVEST OPHTH VIS SCI, V26, P113